期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

骨桥蛋白及基质金属蛋白酶—9在恶性黑素瘤中的表达 被引量：2

Expression of osteopontin and matrix metalloproteinase-9 in human malignant melanoma
原文传递
导出
摘要 目的探讨骨桥蛋白及基质金属蛋白酶-9(MMP-9)在人恶性黑素瘤中的表达及意义。方法采用免疫组化SP法检测23例原发性恶性黑素瘤、17例转移性恶性黑素瘤及20例色素痣中骨桥蛋白和MMP-9的表达。结果40例恶性黑素瘤中骨桥蛋白及MMP-9表达的阳性率分别为87．5％、75．0％；20例色素痣中的阳性表达率分别为15．0％、10．0％。骨桥蛋白及MMP-9在恶性黑素瘤中阳性表达率明显高于色素痣,差异具有统计学意义(P＜0．05)。骨桥蛋白和MMP-9的表达与年龄、性别、发病部位、是否淋巴结转移等因素均无关(P＞0．05)。40例恶性黑素瘤中,骨桥蛋白与MMP-9均表达29例,均不表达4例。结论骨桥蛋白及MMP-9在人恶性黑素瘤中高表达,但与淋巴结转移无相关性。 Objective To investigate the expression of osteopontin and matrix metalloproteinase-9 （ MMP9 ）, and the relationship of osteopontin and MMP9 in malignant melanoma. Methods Expression of osteopontin and MMP9 was measured by immunohistochemical SP method in 23 patients with primary cutaneous malignant melanoma, 17 patients with metastatic melanoma and 20 patients with pigmented nevus. Results Osteopontin and MMP9 were expressed respectively in 87.5% and 75.0% of 40 malignant melanoma specimens, 15.0% and 10.0% of 20 pigmented nevus specimens. The expression of both osteopontin and MMP9 was significantly higher （ both P 〈 0.05 ） in malignant melanoma than in pigmented nevus. There was no correlation between the expression of osteopontin and MMP9, with age, sex, lymph node metastasis or location of lesions （ P 〉 0.05 ）. Twenty-nine cases were positive for both osteopontin and MMP9, 4 negative for either osteopontin or MMP9. Conclusion Both osteopontin and MMP9 were overexpressed in malignant melanoma, but neither was related to lymph node metastasis.
作者 黄长征 杨井 陶娟 陈思远 涂亚庭
机构地区 华中科技大学同济医学院附属协和医院皮肤科
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2006年第6期325-327,共3页 Chinese Journal of Dermatology
关键词 黑色素瘤 明胶酶B 骨桥蛋白 Melanoma Gelatinase B Osteopontin
分类号 R739.5 [医药卫生—肿瘤]
  • 相关文献

参考文献9

  • 1Rittling SR, Chambers AF. Role of osteopontin in tumour progression. Br J Cancer, 2004, 90: 1877-1881.
  • 2Ozdemir E, Kakehi Y, Okuno H, et al. Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas. J Urol, 1999, 161: 1359-1363.
  • 3Nemoto H, Rittling SR, Yoshitake H, et al. Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues.J Bone Miner Res, 2001, 16: 652-659.
  • 4Zhou Y, Dai DL, Martinka M, et al. Osteopontin expression correlates with melanoma invasion. J Invest Dermatol, 2005, 124:1044-1052.
  • 5Farias E, Ranuncolo S, Cresta C, et al. Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients. Int J Cancer, 2000, 89: 389-394.
  • 6Varani J, Hattori Y, Chi Y, et al. Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin. Br J Cancer, 2000, 82:657-665.
  • 7孙现军,姜希宏,侯文红,马恒.骨桥蛋白与MMP-9在胃癌中的表达及其与临床病理特征的关系[J].肿瘤防治杂志,2003,10(4):370-372. 被引量：15
  • 8Jones JL, Walker RA. Control of matrix metalloproteinase activity in cancer. J Pathol, 1997, 183: 377-379.
  • 9Wang-Rodriguez J, Urquidi V, Rivard A, et al. Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status. Breast Cancer Res, 2003, 5: R136-R143.

二级参考文献14

  • 1[1]Crawford HC,Matrisian LM,Liaw L. Distinct role of osteopontin in host defense activity and tumor survival during sqamous cell carcinoma progression in vivo[J].Cancer Res,1998,58(22):5206-5215.
  • 2[2]Takahashi F,Takahashi K,Maeda K,et al. Osteopontin is induced by nitric oxide in RAW264.7 cells[J].IUBMB Life,2000,49(2):217-221.
  • 3[3]Denhardt DT,Giachelli CM,Rittling SR. Role of Osteopontin in celluar signaling ang toxicant injury[J].Ann Rev Pharmacol Toxicol,2001,41(3):723-749.
  • 4[4]Oidberg A,Franzen A,Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding seqence[J].Proc Natl Acad Sci USA,1986,83(5):8819-8823.
  • 5[5]Tuck AB,O'Malley FP,Singhal H,et al. Osteopontin expression in a group of lymph node negative breast cancer patients[J].Int J Cancer (Pred Oncol),1998,79(4):502-508.
  • 6[6]Agrawal D,Chen T,Irby R,et al. Osteopontin identified as lead marker of colon cancer progression,using pooled sample expression profiling[J].J Natl Cancer Inst,2002,94(7):513-521.
  • 7[7]Teruyoshi UE,Yokozaki H,Kitadai Y,et al. Co-Expression of osteopontin and CD44V9 in gastric cancer[J].Int J Cancer,1998,79(1):127-132.
  • 8[8]Craig AM,Bowden GT,Chambers AF,et al. Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts[J].Int J Cancer,1990,46(1):133-137.
  • 9[9]Behrend EI,Craig AM,Wilson SM,et al. Reduced malignancy of ras-transformed NIH3T3 cells expressing antisense osteopontin RNA[J].Cancer Res,1994,54(3):832-837.
  • 10[10]Scorilas A,Karameris A,Arnogiannaki N,et al. Overexpression of matrix-metalloproteinase-9 in human breast cancer:a potential favourable indicator in node-negative patients[J].Br J Cancer,2001,84(11):1488-1496.

共引文献14

同被引文献17

  • 1任传利,桂淑玉,汪渊.骨桥蛋白与肿瘤发生及转移的关系研究进展[J].国外医学（肿瘤学分册）,2004,31(7):489-492. 被引量：1
  • 2Philip S, Bulbule A, Kundu GC. Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type I matrix metalloproteinase in murine melanoma cells. J Biol Chem, 2001, 276( 48 ) : 44926-44935.
  • 3Geissinger E, Weisser C, Fischer P, et al. Autocrine stimulation by osteopontin contributes to antiapoptotic signalling of melanocytes in dermal collagen. Cancer Res, 2002, 62 ( 16 ) : 4820- 4828.
  • 4Zhou Y, Dai DL, Martinka M, et al. Osteopontin expression correlates with melanoma invasion. J Invest Dermatol, 2005, 124 ( 5 ):1044-1052.
  • 5Nelson J, Bagnato A, Battistini B, et al. The endothelin axis: emerging role in cancer. Nat Rev Cancer, 2003, 3 ( 2 ) : 110-116.
  • 6Nemoto H, Rittling SR, Yoshitake H, et al. Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues. J Bone Miner Res, 2001, 16( 4 ) : 652-659.
  • 7Goutam C,Shalini J,Reeti B,et al.The multifaceted roles of osteopontin in cell signaling,tumor progression and angiogenesis[J].Current Molecular Medicine,2006,6,819-830.
  • 8Chang PL,Harkins L,Hsieh YH.et al.Osteopontin expression in normal skin and non-melanoma skin tumors[J].J Histochem Cytochem, 2008,56:57-66.
  • 9Hsieh YH,Juliana MM,Hicks PH et al.Papilloma development is delayed in osteopontin- null mice :implicating an antiapoptosis role for osteopontin[J].Cancer Res,2006,66:7119-7127.
  • 10Bandopadhyay M, Bulbule A,Butti R, et al.Osteopontin as atherapeutic target for cancer[J].Expert Opin Ther Targets, 2014,18(8):883-895.

引证文献2

二级引证文献2

中华皮肤科杂志
2006年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部